Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suros Surgical Systems was a medical technology company specializing in the development of minimally invasive vacuum-assisted breast biopsy devices. The company's flagship product, the ATEC (Automated Tissue Excision and Collection) system, provided a faster and more compassionate alternative to traditional surgical biopsies by allowing for multiple tissue samples through a single small incision. Suros also developed various biopsy markers and access tools to enhance the accuracy of breast cancer diagnosis. In 2006, the company was acquired by Hologic, a leader in women's health, to bolster its interventional breast health portfolio. Today, the technology developed by Suros remains a core component of Hologic's breast biopsy offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suros Surgical Systems.